Pronađeno: 1-5 / 5 radova

Autori: Poddubskaya Elena

>> Filter: Samo Article i Review

>> Sve godine

Naslov Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. (Meeting Abstract)
Autori Trukhin Dmytro Poddubskaya Elena Andric Zoran G  Bondarenko Igor N Shevnia Serhii Zaric Bojan  Bellala Ravishankar Charoentum Chaiyut Perez Luis Bullo Felicitas Garcia Fernanda 
Info JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. -
Projekat mAbxience Research
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. (Meeting Abstract)
Autori Millan Susana Trukhin Dmytro Kolesnik Oleksii Poddubskaya Elena Andric Zoran G  Bondarenko Igor N Shevnia Serhii Bullo Felicitas Sarnago Cristina 
Info JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 15, Suppl. S, str. -
Projekat mAbxience Research SI
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer (Article)
Autori Van Cutsem Eric Hidalgo Manuel Canon Jean-Luc Macarulla Teresa Bazin Igor Poddubskaya Elena Manojlovic Nebojsa S  Radenkovic Dejan V Verslype Chris Eric Raymond Cubillo Antonio Schueler Armin Zhao Charles Hammel Pascal 
Info INTERNATIONAL JOURNAL OF CANCER, (2018), vol. 143 br. 8, str. 2053-2064
Projekat Merck KGaA, Darmstadt, Germany [NCT01016483]; EMD Serono, Inc. [NCT01016483]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. (Meeting Abstract)
Autori Van Cutsem Eric Hidalgo Manuel Bazin Igor Canon Jean-Luc Poddubskaya Elena Manojlovic Nebojsa S  Milella Michele Radenkovic Dejan V Verslype Chris Guo Wei Damstrup Lars Hammel Pascal 
Info JOURNAL OF CLINICAL ONCOLOGY, (2015), vol. 33 br. 3, Suppl. S, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)
Autori Fennell DA Goss GD Andric Zoran G  Bondarenko Igor N Zaric Bojan  Ceric Timur Poddubskaya Elena Teofilovici F Guo W Ramalingam Suresh S 
Info EUROPEAN JOURNAL OF CANCER, (2013), vol. 49 br. , Suppl. 2, str. S801-S801
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX